News

The Adult Small Bowel Program at NYP/Columbia University is making advances in managing patients with intestinal and multivisceral transplants.
Read More >
Blog & Newsletter

The pH Diet: Facts and Fiction

As a digestive disease dietitian, I have been getting a lot of questions surrounding the alkaline diet. Google alone provides over three million results on this topic! The problem is, almost everything you read and hear has zero scientific evidence. People think that an array of digestive diseases, including cancer and reflux, can be prevented or cured if the body is made more alkaline. So, it is time to set the record straight and separate fact from fiction.
Read More >
What's New in the Department of Surgery

The Current Approach to Lymphatic Malformations

NYP/Morgan Stanley Children’s Hospital has one of the top programs in the nation for the diagnosis and treatment of pediatric vascular anomalies. The Vascular Anomalies Group evaluates patients with a variety of vascular tumors, malformations, and associated syndromes including the newly categorized PIK3CA-related overgrowth spectrum (PROS), formerly labeled overgrowth syndromes.
Read More >
What's New in the Department of Surgery

Studies Conflict Regarding Anesthesia in Infants

New data on potential effects of anesthesia on fetal and infant brain development raised concerns at the October Clinical Congress of the American College of Clinical Surgeons. Steven Stylianos, MD, Chief of the Division of Pediatric Surgery at Columbia University Medical Center and Surgeon-in-Chief at NYP/Morgan Stanley Children’s Hospital interprets the new studies, along with Lena S. Sun, MD, Chief, Division of Pediatric Anesthesiology at NYP/Morgan Stanley Children’s Hospital and a leading authority in this field.
Read More >
What's New in the Department of Surgery

Pediatric Intestinal Transplantation and Liver Disease

NYP/Morgan Stanley Children’s Hospital has one of the most advanced pediatric intestinal transplantation and rehabilitation programs in the country. “We have developed new protocols using induction therapy and in last four years, have achieved 100 percent one-year patient survival,” reports Mercedes Martinez, MD, Director of the Intestinal Transplant Program at the Center for Liver Disease. “We also are developing new research studying mechanisms of rejection in these patients. We also have one of the most comprehensive programs in the nation for pediatric liver transplantation with better than expected outcomes for patients and graft survival, at one month, three years and five years.”
Read More >
In December 2016, a retrospective study from the Mayo Clinic indicated that a surgeon can safely be responsible for two overlapping procedures when critical parts of the procedures are not coincident. The study of overlapping operations showed no difference in patient outcomes, but increased effectiveness and time management. Paul Kurlansky, MD, Associate Director of Columbia’s Center for Innovation and Outcomes Research at NYP/Columbia, stresses that there is a big difference between overlapping and concurrent operations. With overlapping procedures, "surgeons cannot be booked to perform critical parts of two operations at the same time," he said. Craig Smith, MD, surgeon-in-chief, NYP/Columbia told Medscape Medical News has been performing overlapping operations routinely for more than 30 years, and he believes his judgment should be trusted with regard to when and how to do them.
Read More >
A recent study published in Circulation shows that patients who take their medication faithfully have dramatically better long-term outcomes, regardless of whether they have CABG or PCI. However, among the non-adherent group, CABG patients fared better with fewer major adverse cardiac events in the years after surgery. “This study shows how important it is to get to know your patients and find out how well they comply with medication,” says Paul Kurlansky, MD, who led the study and is currently director of research for Columbia HeartSource.
Read More >
NYP/Columbia was among the first to offer patients access to Heartmate 3, the newest LVAD technology, in a clinical trial testing it against current standard of treatment, the Heart Mate II. In a randomized study reported in New England Journal of Medicine and presented at American Heart Association in November 2016, lead investigator Yoshifumi Naka, MD, PhD, reported fewer complications with the Heartmate 3, noting a marked improvement over Heartmate II.
Read More >
Not sure how to use cancer fighting spices in your everyday cooking? Try this Overnight Oats with turmeric and ginger in honor of Pancreatic Cancer Awareness Month!
Read More >

Pages